MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TVTX made $1,093,075K in revenue. -$26,655K in net income. Net profit margin of -2.44%.

Income Overview

Revenue
$1,093,075K
Net Income
-$26,655K
Net Profit Margin
-2.44%
EPS
-$0.29
Unit: Thousand (K) dollars
Revenue Breakdown
    • Total revenue-Product
    • Selling, general and administrat...
    • Research and development
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
Total revenue-License
80,268
Total revenue-Product
410,460
Research and development
206,011
Selling, general and administrative
337,202
Restructuring
0
In-process research and development
0
Product
5,813
License
4,526
Cost of goods sold
10,339
Total operating expenses
553,552
Operating loss
-62,824
Interest income
12,721
Interest expense
10,748
Other income (expense), net
11,578
Total other income, net
13,551
Loss from continuing operations before income tax provision
-49,273
Income tax provision on continuing operations
988
Loss from continuing operations, net of tax
-50,261
Income (loss) from discontinued operations, net of tax
24,715
Net loss
-25,546
Unrealized (loss) gain on marketable debt securities
-383
Unrealized gain (loss) on defined benefit pension plan
-219
Foreign currency translation (loss) gain
-945
Comprehensive loss
-26,655
Net loss per common share, basic (in dollars per share)
-0.29
Net loss per common share, diluted (in dollars per share)
-0.29
Weighted average common shares outstanding, basic (in shares)
89,211,813
Weighted average common shares outstanding, diluted (in shares)
89,211,813
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$26,655K Unrealized gain (loss) ondefined benefit pension...-$219K Foreign currencytranslation (loss) gain-$945K Unrealized (loss) gain onmarketable debt securities-$383K Net loss-$25,546K Income (loss) fromdiscontinued operations, net...$24,715K Loss from continuingoperations, net of tax-$50,261K Other income(expense), net$11,578K Interest income$12,721K Income tax provision oncontinuing operations$988K Loss from continuingoperations before income...-$49,273K Total other income,net$13,551K Interest expense$10,748K Operating loss-$62,824K Totalrevenue-Product$410,460K Totalrevenue-License$80,268K Total operatingexpenses$553,552K Cost of goods sold$10,339K Selling, general andadministrative$337,202K Research and development$206,011K License$4,526K Product$5,813K

Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics, Inc. (TVTX)